Tools
Dividend payout calendar
Ex-dividend calendar
Community
You've enabled stealth mode. All money values are hidden.
Disable
Stocks
Japan
Healthcare
4552
JCR Pharmaceuticals Co Ltd
4552
• TSE
¥530.00
¥0.00
(
0%
)
Overview
Dividends
Financials
News
Community
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start
Frequently asked questions
What sector does JCR Pharmaceuticals Co Ltd (4552) operate in?
JCR Pharmaceuticals Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is JCR Pharmaceuticals Co Ltd (4552) current stock price?
As of the latest data, JCR Pharmaceuticals Co Ltd stock price is ¥530, with a previous close of ¥530.
What is JCR Pharmaceuticals Co Ltd (4552) current market capitalization?
JCR Pharmaceuticals Co Ltd market cap is approximately 64.57 billion.
What is JCR Pharmaceuticals Co Ltd (4552) Earnings Per Share (EPS)?
The trailing EPS is -¥38.
What is JCR Pharmaceuticals Co Ltd (4552) EBITDA?
JCR Pharmaceuticals Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.18 billion.
Does JCR Pharmaceuticals Co Ltd (4552) pay dividends?
Yes. JCR Pharmaceuticals Co Ltd pays semiannual dividends with an annualized yield of 3.77% and an estimated annual payout of ¥20 per share.
When is the next ex-dividend date for JCR Pharmaceuticals Co Ltd (4552)?
The next ex-dividend date is scheduled for September 28, 2025.
How did JCR Pharmaceuticals Co Ltd (4552) perform in its most recent earnings report?
In the last report (March 31, 2025), JCR Pharmaceuticals Co Ltd posted an EPS surprise of -7.17% and a revenue surprise of -78.22%.
When is JCR Pharmaceuticals Co Ltd (4552) next earnings report?
JCR Pharmaceuticals Co Ltd is expected to release its next earnings report on June 30, 2025.
What is JCR Pharmaceuticals Co Ltd (4552) beta (volatility) score?
JCR Pharmaceuticals Co Ltd has a beta of 0.017, indicating lower volatility than the overall market.